Ultragenyx Pharmaceutical (RARE) Q3 2017 Earnings

27JulConfirmed
Q4 2016
Q1 2017
Q2 2017
Q3 2017
-1.75
-1.67
-1.59
-1.51

Details

Expected EPS
-1.73
Actual EPS
-1.72
Surprise EPS
0.01
Surprise Percent
+0.58%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -1.72 per share for Q3 2017.

0 Comments

Share your thoughts